Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jennifer DUMOULIN"'
Autor:
Assya Akli, Paul Takam Kamga, Catherine Julie, Claude Capron, Adrien Costantini, Coraline Dumenil, Jennifer Dumoulin, Violaine Giraud, Florence Parent, Andrei Seferian, Catherine Guettier, Mathieu Glorion, Elisabeth Longchampt, Jean-François Emile, Étienne Giroux-Leprieur
Publikováno v:
Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-11 (2025)
Abstract Most of advanced non-small cell lung cancer (NSCLC) patients will experience tumor progression with immunotherapy (IO). Preliminary data suggested an association between high plasma HGF levels and poor response to IO in advanced NSCLC. Our s
Externí odkaz:
https://doaj.org/article/81934d3059b64856a3947078757a9e84
Autor:
Benjamin Davido, Benoit Lemarie, Elyanne Gault, Marion Pepin, Karim Jaffal, Sebastien Beaune, Lotfi Dahmane, Jennifer Dumoulin, Segolene Greffe, Djillali Annane, Pierre De Truchis
Publikováno v:
International Journal of Infectious Diseases, Vol 119, Iss , Pp 217-224 (2022)
ABSTRACT: Background: Following a study of predictors of superinfection in viral respiratory tract infections (VRTIs), this study analyzes the predictors of the outcome. Methods: Multicenter retrospective study conducted among adults who tested posit
Externí odkaz:
https://doaj.org/article/7963c898a0d0466fb8b3925690abbb89
Autor:
Benjamin Davido, Benoit Lemarie, Elyanne Gault, Jennifer Dumoulin, Emma D’anglejan, Sebastien Beaune, Pierre De Truchis
Publikováno v:
Diagnostics, Vol 13, Iss 12, p 2115 (2023)
Introduction: Prior to the emergence of COVID-19, when influenza was the predominant cause of viral respiratory tract infections (VRTIs), this study aimed to analyze the distinct biological abnormalities associated with influenza in outpatient settin
Externí odkaz:
https://doaj.org/article/4b64f2d31f094ce99d9d58d62aeaf8ac
Autor:
Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Dumenil, Nathalie Neveux, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Julie Tisserand, Catherine Julie, Jean-François Emile, Thierry Chinet, Etienne Giroux Leprieur
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstract Background Recent data suggested a role of gut microbiota and antibiotic use on immune checkpoint inhibitors efficacy. We aimed to evaluate the impact of early use of antibiotic (EUA), blood microbiome and plasmatic citrulline (marker of the
Externí odkaz:
https://doaj.org/article/1ac16da7d72d4360a71cc08abea4aa14
Autor:
Jean-François Emile, Coraline Dumenil, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Catherine Julie, Thierry Chinet, Etienne Giroux Leprieur, Zofia Hélias-Rodzewicz, Paul Takam Kamga, Adrien Costantini, Alexandre Corjon, Simon Garinet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Despite prolonged tumor response to immune checkpoint inhibitors (ICIs) for a subset of patients with advanced non-small cell lung cancer (NSCLC), a secondary resistance will occur for a majority of these patients. The understanding of lat
Externí odkaz:
https://doaj.org/article/03dd415e5a6e46c3a728013a99b7763e
Autor:
Philippine Dacosta-Noble, Adrien Costantini, Coraline Dumenil, Jennifer Dumoulin, Pierre Helly de Tauriers, Violaine Giraud, Sylvie Labrune, Jean-François Emile, Jean-Claude Alvarez, Thierry Chinet, Etienne Giroux Leprieur
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219080 (2019)
INTRODUCTION:Patients with advanced non-small cell lung cancer (NSCLC) are most of the time treated with a first-line cytotoxic chemotherapy. Tobacco use is responsible for 90% of lung cancer. The aim of this study was to evaluate the impact of smoki
Externí odkaz:
https://doaj.org/article/cb29f49b0a6c420eb743f97664e3bf32
Autor:
Adrien Costantini, Catherine Julie, Coraline Dumenil, Zofia Hélias-Rodzewicz, Julie Tisserand, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Publikováno v:
OncoImmunology, Vol 7, Iss 8 (2018)
Immune checkpoint inhibitors, as nivolumab, are used in advanced non-small cell lung cancer (NSCLC). However, no associated biomarker is validated in clinical practice with this drug. We investigated herein immune-related blood markers in patients wi
Externí odkaz:
https://doaj.org/article/da287e26617f4bc5a35c7d66a6731c6a
Autor:
Etienne Giroux Leprieur, Guillaume Herbretau, Coraline Dumenil, Catherine Julie, Violaine Giraud, Sylvie Labrune, Jennifer Dumoulin, Julie Tisserand, Jean-François Emile, Hélène Blons, Thierry Chinet
Publikováno v:
OncoImmunology, Vol 7, Iss 5 (2018)
Nivolumab is an anti-PD1 antibody, given in second-line or later treatment in advanced non-small cell lung cancer (NSCLC). The objective of this study was to describe the predictive value of circulating tumor DNA (ctDNA) on the efficacy of nivolumab
Externí odkaz:
https://doaj.org/article/b85a14a64db44194ab6d9474fb505465
Autor:
Coraline Dumenil, Marie-Ange Massiani, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Etienne Giroux Leprieur
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195945 (2018)
The prognosis of advanced non-small-cell lung cancer (NSCLC) has been improved by development of immune checkpoint inhibitors (ICIs) such as nivolumab for second-line treatment. As phase III trials include only selected patients, we here investigated
Externí odkaz:
https://doaj.org/article/8314a72e39144f31b5b5794b2d9b3cee
Autor:
Jamila, Talb, Paul, Takam Kamga, Marie, Mayenga, Adrien, Costantini, Catherine, Julié, Coraline, Dumenil, Jennifer, Dumoulin, Julia, Ouaknine, Violaine, Giraud, Cécile, Dujon, Reza, Azarian, Claire, Glaser, Jean-François, Emile, Etienne, Giroux Leprieur
Publikováno v:
Cancer Immunology, Immunotherapy. 71:2791-2799
Despite high expression of PD-L1, around half of advanced non-small cell lung cancer (NSCLC) will not experience tumor response with pembrolizumab. There is an need for a better understanding of the resistance mechanisms in this setting.This bi-centr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294baf0ddf09083031cfe3fa79dd3f44
https://doi.org/10.1007/s00262-022-03206-4
https://doi.org/10.1007/s00262-022-03206-4